| 2015 | Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients | 편욱범 | Article |
| 2015 | Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients (vol 45, pg 225, 2015) | 편욱범 | Correction |
| 2009 | Are There Differences in Clinical Outcomes after Target Lesion Revascularization for Restenosis According to the Type of Restenosed Drug-Eluting Stent? Comparisons between Sirolimus-versus Paclitaxel-Eluting Stent Restenosis. | 권기환 | Meeting Abstract |
| 2022 | Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study | 김충기 | Article |
| 2020 | Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells | 오구택; 이미니; 서주원; 강인숙 | Article |
| 2021 | Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study | 김충기 | Article |
| 2019 | Favorable neurological outcome after ischemic cerebrovascular events in patients treated with percutaneous left atrial appendage occlusion compared with warfarin | 조인정 | Article |
| 2022 | Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention | 김충기 | Article |
| 2020 | Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents | 신상훈 | Article |
| 2018 | Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux | 강상원; 오구택; 한기환; 박영미; 이미니 | Article |
| 2022 | Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study | 김충기 | Article |
